Anticoagulation in Atrial Fibrillation With Previous Intracranial Bleeding: Competing Adverse Events in a Nationwide Cohort.
BACKGROUND AND OBJECTIVES Patients with atrial fibrillation (AF) and previous intracranial bleeding are at high risk of ischemic and bleeding events, and the benefits and risks of oral anticoagulation (OAC) remain uncertain. We investigated competing risks of recurrent intracranial bleeding, ischemic stroke (IS), and d...